Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2014
05/13/2014CA2552982C Botulinum toxin for treating vascular disorders
05/13/2014CA2542652C Nutritional composition against side effects of chemotherapy or radiotherapy
05/13/2014CA2523998C Novel antimicrobial peptides
05/13/2014CA2514058C Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer
05/13/2014CA2506850C Compounds and methods for increasing neurogenesis
05/13/2014CA2479042C Cartilage regeneration using chondrocyte and tgf-.beta.
05/13/2014CA2441947C Human papilloma virus immunoreactive peptides
05/13/2014CA2404253C Novel ecdysone receptor-based inducible gene expression system
05/13/2014CA2362099C T cell receptor v.beta.-d.beta.-j.beta. sequence and methods for its detection
05/08/2014WO2014071405A2 Long-acting single-chain insulin analogues
05/08/2014WO2014071402A1 Xbp1, cd138, and cs1, pharmaceutical compositions that include the peptides, and methods of using such petides and compositions
05/08/2014WO2014071339A2 Uses of bremelanotide in therapy for female sexual dysfunction
05/08/2014WO2014071282A1 Compositions and methods for treating proteinopathies
05/08/2014WO2014071231A1 Tec family kinase inhibitor adjuvant therapy
05/08/2014WO2014071219A1 Methods and products for expressing proteins in cells
05/08/2014WO2014071183A1 Method of reducing adverse effects in a cancer patient undergoing treatment with a mek inhibitor
05/08/2014WO2014071158A1 Activin-actrii antagonists and uses for treating bone and other disorders
05/08/2014WO2014071132A1 Contact lens surface modification with hyaluronic acid (ha) binding peptide for ha accumulation and retention
05/08/2014WO2014071131A1 Sortilin 1 is a novel inducer of vascular calcification
05/08/2014WO2014071128A1 Macrophage-derived matrix vesicles: an alternative mechanism for microcalcification in atherosclerotic plaques
05/08/2014WO2014071053A2 Improvements on tissue sealant for use in non-compressible hemorrhage
05/08/2014WO2014071032A1 Hepatitis c virus inhibitors
05/08/2014WO2014071007A1 Hepatitis c virus inhibitors
05/08/2014WO2014070974A1 Hepatitis c virus inhibitors
05/08/2014WO2014070965A2 Somatostatin analogs and dimers thereof
05/08/2014WO2014070964A1 Hepatitis c virus inhibitors
05/08/2014WO2014070349A1 Factor ix variants
05/08/2014WO2014070111A1 A novel reagent for gene-drug therapeutics
05/08/2014WO2014069834A1 Three-dimensional crystal structure of snail and importin-beta complex, and crystallization method thereof
05/08/2014WO2014069757A1 Stabilizer for hyaluronidase and liquid formulation comprising hyaluronidase
05/08/2014WO2014069666A1 Agent for preventing or improving decline in brain function
05/08/2014WO2014069523A1 Carnosadine lactam derivative having antibacterial activity
05/08/2014WO2014069401A1 Pulmonary disease-specific therapeutic agent
05/08/2014WO2014068499A1 Use of tryptophan rich protein hydrolysates
05/08/2014WO2014068317A1 Recombinant clostridium botulinum neurotoxins
05/08/2014WO2014068296A1 Fat loss composition
05/08/2014WO2014068085A1 Composition comprising cytokine macro-aggregates
05/08/2014WO2014068023A1 Dpp8 and dpp9 peptide inhibitors
05/08/2014WO2014068012A1 Fc gamma receptor iib variants
05/08/2014WO2014067959A1 A pharmaceutical composition for use in treating or preventing either one or both of an inflammatory disease and an autoimmune disease
05/08/2014WO2014067933A1 Bioactive carrier preparation for enhanced safety in care products and food
05/08/2014WO2014067505A2 Peptides that bind to amino-terminal truncated amyloid-beta-peptide and use of said peptides
05/08/2014WO2014067038A1 Target point, preparation and method for treating human adsl deficiency
05/08/2014WO2014066992A1 Methods for inhibiting platelet aggregation using glp-1 receptor agonists
05/08/2014WO2014066964A1 Pharmaceutical compositions containing a mas receptor agonist for treating degenerative muscular diseases
05/08/2014WO2014066943A1 Reconstituted hdl formulation
05/08/2014WO2014035289A9 A pharmaceutical composition for stimulation of angiogenesis
05/08/2014WO2014028509A3 Thrombopoietin mimetics for the treatment of radiation or chemical induced bone marrow injury
05/08/2014WO2014014816A3 Methods of treating glucose metabolism disorders
05/08/2014WO2013136193A8 Methods and compositions for modulating toso activity
05/08/2014WO2013056054A9 Peptide inhibitors of bace1
05/08/2014WO2013040547A3 Compounds and methods of immunization with tumor antigens
05/08/2014WO2013040093A3 Glucagon-like peptide-2 compositions and methods of making and using same
05/08/2014WO2013033396A3 Fap-activated proteasome inhibitors for treating solid tumors
05/08/2014WO2013033206A3 Compositions and methods for inhibiting ccl3
05/08/2014WO2013012743A3 Methods and compositions for inhibiting staphylococcus agglutination in blood
05/08/2014WO2013009755A3 Method of use of activated functional proteins to improve animal health
05/08/2014WO2012170918A3 Methods of treatment for retinal diseases
05/08/2014WO2012166617A3 Methods, compositions, and kits for the treatment of cancer
05/08/2014WO2012162547A3 Long duration dual hormone conjugates
05/08/2014WO2012155124A3 Metallodrugs having improved pharmacological properties, and methods of manufacture and use thereof
05/08/2014WO2012154894A3 Integrin receptor antagonists and their methods of use
05/08/2014WO2012149515A3 Novel vegf mimetic peptide-based scaffolds for therapeutic angiogenesis and methods for their use
05/08/2014WO2012149389A3 Methods of treating alzheimer's disease, huntington's disease, autism, or other disorders
05/08/2014WO2012149254A3 Mfg-e8 and uses thereof
05/08/2014WO2012138739A3 Compositions and methods for treating cancer
05/08/2014US20140128590 Hydrolases, nucleic acids encoding them and methods for making and using them
05/08/2014US20140128457 Therapeutic ribonucleases
05/08/2014US20140128329 Ophthalmic compositions comprising polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymers
05/08/2014US20140128328 Peptide antagonists of zonulin and methods for use of the same
05/08/2014US20140128325 Von willebrand factor or factor viii and von willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes
05/08/2014US20140128323 Method for prevention or treatment of diabetic angiogenesis impairment using C-peptide
05/08/2014US20140128322 Compositions for Controlling Neuronal Outgrowth
05/08/2014US20140128321 Method and use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
05/08/2014US20140128318 Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
05/08/2014US20140128317 Antiviral agent comprising recombinant mistletoe lectins
05/08/2014US20140128316 Integrase cofactor
05/08/2014US20140128315 Caspofungin or salts thereof with high purity, as well as preparation method and use thereof
05/08/2014US20140127751 Wise/sost nucleic acid sequences and amino acid sequences
05/08/2014US20140127327 Preserved topical formulations with improved antimicrobial activity
05/08/2014US20140127320 Delivery of biologically-active agents using volatile, hydrophobic solvents
05/08/2014US20140127307 Micropellet compositions comprising pancreatin containing digestive enzyme mixture
05/08/2014US20140127303 Sustained-release composition containing peptides as active ingredient
05/08/2014US20140127301 Adjuvant Incorporation in Immunonanotherapeutics
05/08/2014US20140127278 Method Of Treating Vascular Disease In Diabetic Patients
05/08/2014US20140127250 Staphylococcus aureus proteins and nucleic acids
05/08/2014US20140127245 Small Peptides And Methods For Treatment Of Chronic Obstructive Pulmonary Disease
05/08/2014US20140127242 Novel and powerful mhc-class ii peptides derived from survivin
05/08/2014US20140127233 Pharmaceutical composition for treating ischemic events
05/08/2014US20140127227 Protein formulations containing amino acids
05/08/2014US20140127218 Pharmaceutical compositions and methods to vaccinate against candidiasis
05/08/2014US20140127201 Compositions and methods related to graft versus host disease and treatments thereof
05/08/2014US20140127188 Method for treatment of adipose deposits
05/08/2014US20140127186 Pharmaceutical composition for treating scars on the skin, and method for treating scars on the skin using same
05/08/2014US20140127185 Methods and compositions using neuroprotective steroids and thrombolytic agents
05/08/2014US20140127184 Compounds for the treatment of neuropsychiatric disorders
05/08/2014US20140127183 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
05/08/2014US20140127182 Using GNMT as a Novel Therapeutic or Preventing Agent for Fatty Liver Related Diseases
05/08/2014US20140127181 Stabilised Compositions of Factor VII Polypeptides
05/08/2014US20140127163 Use of slurp1 as an imunomodulatory molecule in the ocular surface
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 3163